In individuals with PKU, a deficiency in the enzyme phenylalanine hydroxylase prevents the conversion of phenylalanine to tyrosine. This leads to elevated levels of phenylalanine in the blood, which can cross the blood-brain barrier and result in neurological damage, intellectual disability, and other health issues. Therefore, controlling phenylalanine intake is essential to prevent these toxic effects.
